Skw Trostberg Aktiengesellschaft

Ralf J&auml;ger

Ivo Pischel

Brigitta Schwartz

Helen Louise Holland

Andrea Huber

The invention relates to the use of creatine and/or creatine derivatives for treating typical disorders in women, for example PMS or dysmenorrhea, which involves the prophylactic of therapeutic use, in particular, of creatine monohydrate, creatine pyruvates, creatine ascorbates and creatine &agr;-ketoglutarates as creatine derivatives in preferred daily doses of 0.1 g to 20 g. The invention also provides for the use of creatine or its derivatives as mixtures with a pyruvate, ascorbate or &agr;-ketoglutarate. The creatine or its appropriate derivatives are not restricted to any particular form of application, which makes them all the more suitable for the many symptoms of typical female disorders.

Growing community of inventors

Trostberg, Germany

Ralf Jäger

Growing community of inventors

Trostberg, Germany

Ralf J&auml;ger

Ralf Jäger